The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

CAR-T ICU 2019 | CAR-T in the UK: updates from King’s College Hospital

Name: CAR-T in the UK: updates from King’s College Hospital
Uploaded: 2019-07-10T08:41:02.000Z
Duration: 2 min 47 s
Description: Robin Sanderson, MBBS, PhD, King's College Hospital NHS Foundation Trust, London, UK, presents updates from the CAR T-cell therapy program at his institute. This interview took place at the CAR-T Cell Therapy and the ICU meeting in London, UK, which was organized by EuroCARTForce.

Robin Sanderson • 10 Jul 2019

CAR-T ICU 2019

Lymphoma CAR-T Tocilizumab

Robin Sanderson, MBBS, PhD, King’s College Hospital NHS Foundation Trust, London, UK, presents updates from the CAR T-cell therapy program at his institute. This interview took place at the CAR-T Cell Therapy and the ICU meeting in London, UK, which was organized by EuroCARTForce.